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Summary. The effects of the host's immune response on metastatic spread was
investigated by observing the numbers of pulmonary metastases that developed
from an s.c. implant of the Lewis lung carcinoma in C57BL mice in which different
cell populations had been suppressed. Macrophage function was impaired by
treatment with silica (Si), cortisone acetate (CA), or trypan blue (TB). T-cell
function was depressed by adult thymectomy and sublethal irradiation, or by treat-
ment with antilymphocyte serum (ALS).
Metastasis was significantly increased and phagocytic activity decreased by Si
and CA, but were unaffected by TB. Thymectomy and irradiation had no effect on
metastases, whereas ALS when given before, but not after tumour growth, reduced
their number.
The antimetastatic action of the immunopotentiating agent C. parvum was
investigated in these immunologically impaired mice. It was unaffected by Si, CA
or TB. However, the inhibiting effect of these agents on phagocytic activity was
overcome by treatment with C. parvum. Its antimetastatic action was unaffected
in mice which had been thymectomized and irradiated, but could be abrogated by
ALS. However, ALS was only able to prevent this activity if given before tumour
growth; it was ineffective if given after tumour growth.
This study showed that metastatic spread was inversely related to phagocytic
activity. The antimetastatic effect of C. parvum appears to be mediated through
macrophages in concert with a subpopulation of T lymphocytes, which were con-
sidered to be necessary in the sensitization arm of the response as opposed to the
effector arm of this response.
ALTHOUGH successful treatment of
patients with primary neoplasms is often
possible, death frequently occurs from
disseminated tumour. However, there
is evidence from animal studies that the
immunological response of the host deals
more effectively with distant foci than
with a single primary tumour (Milas et
al., 1974) and immunotherapy may be
more effective in this situation.
Killed Corynebacteriurn parvum is a
powerful immunopotentiating agent (Hal-
pern et al., 1963; Biozzi et al., 1968;
Howard, Christie and Scott, 1973) and
it inhibits the growth of a variety of
primary and metastatic rodent tumours
(Halpern et al., 1966; Woodruff and
Boak, 1966; Smith and Scott, 1972;
Proctor, Rudenstam and Alexander, 1973;
Sadler and Castro, 1976).
To investigate the effects of the host's
immune response on disseminated tumour
and in the antimetastatic action of C.
parvum, mice bearing the metastasizing
Lewis lung carcinoma were treated to
suppress selectively the separate com-
ponents of this response.
MATERIALS AND METHODS
Mice.-Adult sex- and age-matched
* Present address: Dept. of Immunopathology, Research and Development Division, G. D. Searle & Co.
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C57BL/10 Sc Sn mice (OLAC Southern
Ltd) were used.
Tumour.-The Lewis lung carcinoma
(Sugiura and Stock, 1955) was transplanted
s.c. as a 0 1-ml homogenate in the lower flank.
When implanted s.c., it metastasizes to the
lungs (Simpson-Herren, Sanford and Holm-
quist, 1974). Twenty-one days after tumour
inoculation, the number of metastases was
determined after inflating the lungs with a
dilute solution of indian ink and fixing in
Fekete's solution (Wexler, 1966). Lungs with
>100 metastases were scored as having 100.
The numbers of metastases in the different
experimental groups were compared by
Student's t test. Throughout this paper, the
day of tumour inoculation is referred to as
Day 0.
Silica.-Silica (Si) (Dorentrup Quartz
Nr. 12 (1-5 ,um)) was sterilized by dry
heating at 160°C for 2 h. The Si dust
was suspended in sterile 0 15 M saline and
exposed for 2 min to ultrasonic vibration
immediately before use. Mice were given
0.2 ml Si (12-5 mg/ml) i.v. and 3 h later
0 5 ml Si (50 mg/ml) i.p., either on Days -1
and +4, or +4 and +9 from tumour
implantation. Controls received an equi-
valent volume ofsaline.
Cortisone acetate.-Cortisone acetate (CA)
(Sigma, C-3130) was suspended at a con-
centration of 25 mg/ml in 0-15 M saline.
Experimental mice received 0-1 ml of CA
s.c. (Scott, 1975) and controls saline at a
site contralateral to tumour implantation
on Day +4 alone or on Days +4 and +11
after tumour implantation.
Trypan blue.-Trypan blue (TB) (B.D.H.,
C.I. 23850-for vital staining) was dialysed
for 48 h against glass-distilled water, lyo-
philized and resuspended at a concentration
of 10 mg/ml in 0-15 M saline. Mice were
given 0-4 ml TB i.p. at 24 h and 0-1 ml
i.p. at 3 h prior to tumour implantation.
A maintenance dose of TB, 0-1 ml s.c. twice
weekly, was given on the contralateral
side to the tumour implant. Control mice
received the same volume of saline (Hibbs,
1975).
Phagocytic index.-The global phagocytic
index (K) was measured by clearance of
colloidal carbon from the blood, using
modifications of the technique described
by Biozzi et al. (1954). Mice were bled
from the retro-orbital sinus, using Unibore
" break-off " 0-02-ml Benjamin heparinized
haematocrit tubes (Harshaw Chemicals Ltd)
before, and at precise times, approximately
2, 5, 10, 15 and 20 min after i.v. injection
of colloidal carbon (14.5% Pelikan ink,
1% gelatin in water, given as 0-01 ml/g
body wt.). The blood was lysed in 2 ml
of water and the optical densities (O.D.)
determined in a Unicam colorimeter with
a 640-nm red filter. K was calculated for
each mouse by the method of least squares
as a regression coefficient, multiplied by
-1, of the straight line relating the loga-
rithms of the O.D. readings plotted against
time. A combined estimate of K ± s.e.
was determined for groups of 3 mice on
various days throughout an experiment,
unless otherwise stated.
Thymectomy and irradiation.-Adult mice
were thymectomized under Nembutal anaes-
thesia (Castro, 1974). Two weeks later
they received 450R whole-body sublethal
irradiation. Tumour was inoculated after a
further 4 weeks.
Antilymphocyte serum.-025 ml rabbit
anti-AKR mouse thymocyte serum (ALS)
(Searle Diagnostics Ltd, Batch 10-pre-
pared by a standard 2-pulse inoculation
schedule) was given s.c. either on Days
-2, -1, 0, +7, +14 or on Days +5, +6,
+7 and +14 from tumour implantation.
Control mice received normal rabbit serum
(NRS).
C. parvum.-A formalin-killed suspension
of C. parvum (Wellcome, Strain CN 6134,
(Batch PX416 for CA studies, Batch PX374
for all others) 7 mg dry wt/ml) was used
at a concentration of 2-33 mg/ml in 0-15 M
saline. Mice receiving C. parvum were
given 0-2 ml i.v. into a lateral tail vein on
the same day as tumour implantation,
or 7 days later. Control mice received the
same volume of0-15 M saline.
RESULTS
C. parvum administered on Day 0 or
Day +7 was equally effective at inhibiting
pulmonary metastasis (significance P <
0-001) (Table I).
Macrophage impairment
Macrophage activity was impaired
with silica (Si), cortisone acetate (CA),
or trypan blue (TB) (see Table I).
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TABLE I.-Influence of Mlacrophage Impairment an Pulmun(ry Jletastases and
the Antiimetastatic Effects of C. parvum (Mfean ± s.d.)
Impairment by treatment with
Si. Davs Si. Davs CA, CA, Days
Group -4, -9 -1, -4 Day -4 -4, -11 TB
a. Tumour (control) 47-21 38-10 50-22 500 36-20
b. Tumour-impairment 81-23 100- 74-23 92-17 43-10
c. Tumour-C.partumDayfl 5-1 12-5 11-7 11-7 9=7
d. Tumour-C'. parr-um DayO 13-6 51 =2) 13-6 37-24 8-7
- impairment
e. Tumour-C'. parrunm Day 7 15-6 8=7
f. Tumour-C. parr-um Day 7 12=8 13=7
- impairment
P. bv Student's t test a:b<0*01 a:b.a:c,c:d a:b<0-05 c:d<001 a:c, d:e, b:d
a:c. a:e, b:d, and a:c, b:d and a:b, a:c, and and
and b:d<0001 a:d<0-001 b:d<0001 b:f<0 001
b:f<0-001 a:d NS c:d XS a:d NS a:b,c:d,c:e
c:d. e:f and d:fande:fNS
d:f NS
NS: not significant.
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FIG. 1. Effects of silica (Si) on Days 4 and 9 after tumour implantation and C. parrrum (Cp) on
Day 7, on the phagocytic index (K) of mice bearing Lewis tumour: untreated control - ;
tumour alone tumour - Si - - -; turmour - Cp -*; and turmour - Si - Cp
-. Each point is the combined estimate from 3 mice. One standard error is shown above
and below the line.
Silica +7 the number of metastases was reduced
Si on Days -4 and +9 increased (P < 0-001) to a level not significantly
metastases from 47 in control mice to different from that found in mice given C.
81 (P < 0-01), but after additional treat- parrum alone. Phagocvtic index decreas-
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FIG. 2. Effects of silica (Si), on Days -1 and +4 from tumour implantation, and C. parvum
(Cp), on Day 0, on the phagocytic index (K) of mice bearing Lewis tumour: untreated control
; tumour alone tumour + Si---; tumour + Cp -*; and tumour +
+ Cp - Each point is the combined estimate from .3 mice. One standard error is
shown above and below the line.
cantly increased after C. parvurn (Fig. 1).
C. parvum in combination with Si in-
creased the index to a value intermediate
to that of untreated and C. parvum-
treated tumour-bearing mice.
Si on Days -I and +4 had more
effect on metastases, increasing them
from 38 in controls to 100-k (P < 0-001).
C. parvum given on Day 0 to mice treated
with Si reduced metastases from 100+
to 51 (P < 0.001). However, there was
no significant difference between the
number of metastases found in these
mice and saline-treated controls, and in
both groups the number was significantly
higher than in mice given C. parvum
alone (mean 12, P < 0-001). Phagocytic
index was again reduced for a short time
after Si and increased after C. parvum (Fig.
2), whereas after Si and C. parvum in com-
bination, it was not significantly different
fromthatinuntreatedtumour-bearingmice.
Cortisone acetate
CA given on Day +4 increased
metastases from 50 in controls to 74
(P + 0.05). If it was given on both
Days +4 and + 11 the increase was
greater (mean 92, P < 0-001). C. par-
vum, given on Day 0 to mice receiving
CA on Day +4, caused a significant
inhibition of metastases from 74 to
13, a number not significantly different
from that in mice receiving C. parvum
alone.
In mice given 2 doses of CA, C.
parvum inhibited metastases from 92 to
37 (P < 0-001), but this number was
higher than that found in mice given
C. parvum alone (mean 11, P < 0-001)
and not significantly different from that
found in saline-treated controls (mean
50).
The phagocytic index (Fig. 3) in
mice given CA was significantly less
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FIG. 3. Effects of cortisone acetate (CA), on Days 4 and 11 after tumour implantation, and C.
parvum (Cp) on Day 0, on the phagocytic index (K) of mice bearing Lewis tumour: untreated
control - *; tumour alone ; tumour + CA - - -; tumour + Cp -* ; and
tumour + CA + Cp - - - - - . Each point is the comibined estimate from 3 mice. One standard
error is shown above and below the line.
than in untreated tumour-bearing mice,
whereas in those given C, parvum it was
significantly greater. Combined C. par-
vum and CA gave values intermediate
to those obtained after the individual
treatments, though greater than that
found in untreated tumour-bearing mice.
Trypan blue
TB was given before and during
tumour growth and C. parvum given
either on Day 0 or +7. TB did not
significantly influence metastasis nor did
it affect the protection afforded by C.
parvum. The phagocytic index of tu-
mour-bearing mice given C. parvum on
Day 0, TB, or both, was determined on
Day +10 (Table II). There was no
significant difference between values in
mice given TB and untreated controls.
C. parvum in combination with TB
increased phagocytic index to a value
TABLE II.-Effects of Trypan Blue (TB)
on the Phagocytic Index of Mice with
Lewis Tumour. C. parvum (Cp) Given
on Day 0
Treatment
Control, non-tumour-bearers
Tumour
Tumour+TB
Tumou.r+TB+Cp
Tumour+Cp
Phagocytic
No. index
mice (+s.e.)
4 0-0454i0*002
2 0*083±Q* 08
2 0*083± i 008
2 0-110±0-006
3 0-141±0-004
intermediate to that found in untreated
tumour-bearing mice and tumour bearers
given C. parvum alone.
T-cell impairment
T cells were depressed either by
thymectomy and irradiation or by ALS
(Table III).
0.30
0.25.
c 0.20.
cOlC 5-
0.10-
0.05.
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TABLE III.-Influence of T-Cell Impairment on Pulmonary Metastases and the
the Antimetastatic Effects of C. Parvum (Mean i s.d.)
Impairment by
Group
a. Tumour
b. Tumour+ impairment
c. Tumour+C. parvum Day 0
d. Tumour+ C. parvum Day 0+impair]
P by Student's t test
* ALS on Days -2, -1, 0, +7 and
t ALS on Days +5, +6, +7 and +
NS: not significant.
Thymectomy and irradiation
No significant difference M
between numbers of metastases
ectomized, irradiated experime
and control mice (Table III). C
given at the same time as t
experimental mice, caused an
of metastases from 45 to 14 (P
a value similar to that found in (
treated controls.
Antilymphocyte serum
ALS inhibited metastases w
before tumour, from 59 in cl
24 (P < 0 01) (Table III), but
given after (means 54 and 41).
C. parvum given to mice tha
ALS before tumour had no anti]
effect. However, the number
stases in this group (mean
significantly greater than in
given C. parvunt (mean 14; J
In contrast, when ALS wa,
until after tumour inoculation,
inhibited the number of metast
41 to 11; P < 0 01) to a value
control mice given C. parvum (i
DISCUSSION
The possible role of the
response, both in the control of
and in the antimetastatic act
parvum, was investigated by (
different cell populations thoul
Thymectomy
and sublethal
irradiation ALS* ALSt
42±15 59+12 54+30
45±23 24+9 41±21
9+5 14+6 10±4
ment 14+11 29±13 11+8
a:c and b:d <0-001 a:bandc:d <0-01 a:dandb:d <0-01
a:bandc:d NS a:c< 0-001 a:bandc:d NS
b:d NS
+14.
-14.
important in this response and observing
vas found the effect on pulmonary metastases.
in thym- Macrophage function was impaired by
,ntal mice treatment with Si, CA, or TB. Silica
7.parvum, is a specific macrophage toxin (Kessel,
umour to Monaco and Marchisio, 1963) which causes
inhibition autolysosomal destruction ofmacrophages
< 0.001), in vitro (Allison, Harrington and Birbeck,
7. parvum- 1966) and inhibits their activity in vivo
(Pearsall and Weiser, 1968; Levy and
Wheelock, 1975). In vivo CA depresses
macrophage activity (Conning and Hep-
rhen given pleston, 1966; Wiener etal., 1967; Thomp-
ontrols to son and van Furth, 1970) and affects
not when cortical thymic T cells (Claman, 1972).
TB inhibits lysosomal enzymes of macro-
tt received phages (Beck, Lloyd and Griffiths, 1967)
metastatic and abrogates non-specific resistance to
of meta- growth of ascitic tumour in mice treated
29) was with BCG or toxoplasma (Hibbs, 1975).
controls We found that mice were unable
P < 0.01). to tolerate more than two doses of Si
s delayed at 5-day intervals. Si increased meta-
C. parvum stasis, and this was greater when it was
ases (from given on Days - 1 and +4 rather than
- found in on Days +4 and +9. CA also increased
mean 10). metastasis, and this effect was more
marked when a second dose was given.
These increases of metastases were not
a direct reflection of primary tumour
immune growth, as this was depressed (paper in
metastasis preparation). A similar increase of lung
;ion of C. tumour nodules has been reported after
depressing gold salts, which inhibit lysosomal enzyme
ght to be activity of macrophages (McBride, Tuach
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and Marmion, 1975). However, in our
experiments TB, which has a similar
effect on macrophages, did not influence
metastasis. This difference is difficult to
explain, for doses of TB were similar to
those described by Hibbs (1975) who
showed facilitation of the growth of an
allogeneic mouse tumour. However, we
also found the phagocytic index of mice
given TB was unchanged, whereas both
Si and CA depressed it. Thus a de-
pression of phagocytic index may be
necessary for an increase of metastases.
C.parvumsignificantlydecreased meta-
stasis in mice given Si, CA or TB. This
result was unexpected, as there is con-
siderable evidence for the involvement
of macrophages in the antitumour action
of C. parvum (Ghaffar, Cullen and Wood-
ruff, 1975; Christie and Bomford, 1975).
However, measurement of phagocytic
index showed C. parvum was able to
overcome, to a limited extent, inhibition
of macrophage activity produced by Si
or CA, probably by increasing macrophage
production (Wolmark and Fisher, 1974;
Warr and Sljivic, 1974). Furthermore,
metastasis appeared to be inversely re-
lated to the host phagocytic activity.
T cells were depressed, either by
thymectomy and sublethal irradiation,
which depletes mainlyshort-lived lympho-
cytes or T1 cells (Kappler et al., 1974) or
by treatment with ALS, which destroys
mainly long-lived circulating lymphocytes
or T2 cells (Lance, Medawar and Taub,
1973; Araneo, Marrack and Kappler,
1975).
We found that depression of T cells
by thymectomy and irradiation did not
alter the number of metastases, but
Carnaud, Hoch and Trainin (1974), using
the same system, reported a significant
increase. Nor did this treatment affect
the antimetastatic action of C. parvum.
Depression of T cells by ALS treat-
ment begun 5 days after tumour inocula-
tion had no effect on metastasis, whereas
ALS given before and during tumour
growth significantly inhibited it. This
suggests that, for optimal metastasis,
a population of ALS-sensitive T cells is
required at the time of tumour inocula-
tion.
ALS given before and during tumour
growth abrogated the antimetastatic
action of C. parvum. We reported this
in our previous paper (Sadler and Castro,
1976) in which we also showed that
this treatment did not affect the phago-
cytic index. We suggested that the
action of C. parvum on metastases was
dependent upon a specific population of
T cells present in mice thymectomized
and sublethally irradiated, but not in
ALS-treated mice. The present study
shows that if ALS treatment was begun
5 days after tumour implantation, at a
time when tumour cells are first released
from the primary tumour (James and
Salsbury, 1974) then the antimetastatic
action of C. parvum was unaffected.
This suggests that although the ALS-
sensitive cells are not the effector cells
in the antimetastatic response, they are
necessary in the sensitization arm of this
response.
We can therefore conclude from this
study that macrophages are important
in preventing the natural spread of
metastases from a primary tumour. Sys-
temic C. parvum given on the day of
tumour implantation or 7 days later,
causes an equally drastic reduction in
metastases probably through macrophage
activation. A sub-population of T cells
present in thymectomized and sublethally
irradiated, but not ALS-treated mice
enhances metastatic spread. A similarly
defined population of T cells is necessary
for the antimetastatic action ofC. parvum,
and probably brings about macrophage
activation. Further studies are under
way to elucidate the precise T-cell popula-
tions involved.
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